Commonwealth Numbered Regulations
[Index]
[Table]
[Search]
[Search this Regulation]
[Notes]
[Noteup]
[Previous]
[Download]
[Help]
1985 No. 184 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 5
SCHEDULE 5
Sub-regulations 14 (1) and (2),
paragraphs 19 (1) (h) and 21 (1) (e)
and sub-regulation 22 (2) PRESCRIBING OF PHARMACEUTICAL BENEFITS SUBJECT TO
CONDITIONS AND
RESTRICTIONS
------------------------------------------------------------------------------
--
Column 1 Column 2 Column 3
Classes of persons, diseases, &c.,
purposes and
conditions specified in relation to
the
Item Pharmaceutical benefit pharmaceutical benefit
------------------------------------------------------------------------------
--
1 Acetylcysteine, B.P. . . . Bronchiectasis
Cystic fibrosis (mucoviscidosis)
2 Acrylic Resin . . . . . . . Ileostomy or colostomy conditions
3 Acyclovir . . . . . . . . . Eye infections caused by herpes
simplex virus where idoxuridine has
proved ineffective
4 "ALBUMAID XP" . . . . . . . Phenylketonuria
5 "ALFARE" . . . . . . . . . With the written authority of the
Secretary-
Cystic fibrosis
Enterokinase deficiency
Intolerance to both milk protein
and soya protein
Severe diarrhoea of greater than
two weeks duration in infants under
the age of 4 months
6 Amantadine Hydrochloride . The treatment of Parkinson's
disease
causedotherwise than by treatment
with a drug
7 Aminoglutethimide . . . . . With the written authority of the
Secretary-
Adrenal suppression in
post-menopausal metastatic breast
cancer in patients who have failed
to respond adequately to primary
endocrine manipulation
Cushing's syndrome
8 (1) "AMINOGRAN FOOD
SUPPLEMENT" Phenylketonuria
(2) "AMINOGRAN MINERAL
MIXTURE"
9 Amiodarone Hydrochloride . With the written authority of the
Secretary-
For the continuing treatment of
severe refractory cardiac
arrhythmias where treatment with
amiodarone hydrochloride was
initiated in a hospital
For the continuing treatment of a
patient who has already received,
for more than 6 months, therapy with
amiodarone hydrochloride for severe
refractory cardiac arrhythmias
10 Amitriptyline Tablets, B.P.
, 50 mg With the written authority of the
Secretary- Endogenous depression
where there is an inadequate
response to not less than100 mg of
amitriptyline hydrochloride daily
11 Amoxycillin Trihydrate, B.
P., Dispersible Tablets Infection of the lower urinary
tract
12 Amylobarbitone Sodium, B.P. Epilepsy
13 Azathioprine Tablets, B.P. With the written authority of the
Secretary-
Anaemia, autoimmune, haemolytic
Arthritis, rheumatoid with
vasculitis or visceral complications
Continuing azathioprine therapy
initiated in a hospital
Crohn's disease
Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active, chronic
Lupus erythematosus, systemic
Nephrotic syndrome
Organ transplant
Pemphigus
Polyarteritis nodosa
Pyoderma gangrenosum
Scleroderma
Thrombocytopenic purpura
Ulcerative colitis
14 "BANISH" . . . . . . . . . Ileostomy or colostomy conditions
15 Bassorin with Frangula
Bark, B.P. Any disease or condition in a
paraplegic or quadriplegic patient
For use by patients who are
receiving long-term extensive
nursing care in hospitals or nursing
homes
For use by patients for whose care a
Commonwealth Domiciliary Nursing
Care Benefit is approved
16 Beclomethasone
Dipropionate, B.P. Chronic intractable asthma
17 Benzoin Compound Tincture,
B.P., Aerosol Spray Ileostomy or colostomy conditions
18 Betamethasone Acetate with
Betamethasone Sodium
Phosphate, B.P., Injection Alopecia areata
For local intra-articular or
peri-articular infiltration
Granulomata, dermal
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
Necrobiosis lipoidica
Uveitis
19 Bisacodyl, B.P. Any disease or condition in a
paraplegic or quadriplegic patient
20 (1) Bisacodyl
Suppositories, B.P. (2)
Bisacodyl Tablets, B.P. Any disease or condition in a
paraplegic or quadriplegic patient
For use by patients who are
receiving long-term extensive
nursing care in hospitals or nursing
homes
For use by patients for whose care a
Commonwealth Domiciliary Nursing
Care Benefit is approved
21 Bleomycin Sulphate . . . . Germ cell neoplasms
Lymphoma
Squamous cellcarcinoma
22 Bromocriptine Mesylate . . With the written authority of the
Secretary-
Acromegaly, prior to surgery or
radiotherapy or where surgery or
radiotherapy is inappropriate
Parkinson's disease where treatment
with levodopa is unsatisfactory
Pathological hyperprolactinaemia
where appropriate surgery or
radiotherapy are not indicated or
have already been used with
incomplete resolution
23 (1) Butyl Monoester
Polymer with Ethanol, B.P. Ileostomy or colostomy conditions
(2) Butyl Monoester
Polymer with Isopropyl
Alcohol, B.P.
24 Calciferol Tablets,
High-Strength, B.P. Hypocalcaemia
Hypoparathyroidism
Osteomalacia following gastrectomy,
severe steatorrhoea or renal failure
Vitamin D-resistant rickets
25 Calcitriol . . . . . . . . With the written authority of the
Secretary-
Hypocalcaemia due to renal disease
Hypoparathyroidism
Vitamin D-resistant rickets
26 Calcium Carbonate, B.P.,
with Calcium
Lactate-Gluconate With the written authority of the
Secretary- Hypocalcaemia
Osteoporosis
Proven malabsorption
27 Calcium Folinate, Injection Antidote to folic acid antagonists
28 Calcium Folinate, Tablets . With the written authority of the
Secretary-
Antidote to folic acid antagonists
29 Captopril . . . . . . . . . With the written authority of the
Secretary-
Severe hypertension
For the continuing treatment of
severe refractory cardiac failure
where treatment with captopril was
initiated in a hospital
30 Carbenicillin Sodium, B.P. Infections where positive
bacteriological evidence confirms
that carbenicillin is the most
appropriate therapeutic agent
Septicaemia, suspected or proven
31 Carindacillin Sodium . . . With the written authority of the
Secretary-
Urinary tract infections where
positive bacteriological evidence
confirms that carindacillin or
carbenicillin is the most
appropriate therapeutic agent
32 Carmellose Sodium, B.P.,
with Pectin and Gelatin, B.
P. Ileostomy or colostomy conditions
33 Cefotaxime Sodium . . . . . Infections where positive
bacteriological evidence confirms
that cefotaxime sodium is the most
appropriate therapeutic agent
Septicaemia, suspected or proven
34 (1) Cephalexin, B.P.,
with Purified Water, B.P. With the written authority of the
Secretary-
(2) Cephalexin Capsules,
B.P. Infections where both clinical and
bacteriological evidence suggest
that cephalexin is the most
appropriate therapeutic agent
35 Cephalothin Sodium, B.P. . Infections where positive
bacteriological evidence confirms
that cephalothin sodium is the most
appropriate therapeutic agent
Septicaemia, suspected or proven
36 Cephazolin Sodium . . . . . Infections where positive
bacteriological evidence confirms
that cephazolin sodium is the most
appropriate therapeutic agent
Septicaemia, suspected or proven
37 Charcoal, Activated, B.P. . Ileostomy or colostomy conditions
38 Chlorambucil Tablets, B.P. With the written authority of the
Secretary-
Anaemia, autoimmune, haemolytic
Arthritis, rheumatoid with
vasculitis or visceral complications
Carcinoma of the breast
Carcinoma of the ovary
Continuing chlorambucil therapy
initiated in a hospital
Granulomatosis, Wegener's
Leukaemia, chronic lymphatic
Lupus erythematosus, systemic
Lymphoma
Myeloproliferative disorders
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
39 Chloramine, B.P. . . . . . Ileostomy or colostomy conditions
40 (1) Chloramphenicol
Capsules, B.P. (2)
Chloramphenicol Palmitate
Mixture, B.P. (3)
Chloramphenicol Sodium
Succi- nate, B.P. Bacterial meningitis
Intraocular infections
Rickettsioses
Typhoid
The treatment of other serious
infections in a patient where it is
established by appropriate
bacteriological testing that
chloramphenicol is the only suitable
antibiotic listed as a
pharmaceutical benefit for use in
treating the infection in the patient
41 Chlormethiazole Capsules,
B.P. . . . . . . . . . . . With the written authority of the
Secretary-
Short-term alcohol or drug
withdrawal therapy in a hospital or
approved centre
Status epilepticus
42 Chlormethiazole Edisylate,
B.P. . . . . . . . . . . . Short-term alcohol or drug
withdrawal therapy in a hospital or
approved centre
Status epilepticus
43 (1) Chlorpromazine Elixir,
B.P. (2) Chlorpromazine
Injection, B.P. (3)
Chlorpromazine
Suppositories, B.P.
(4) Chlorpromazine
Tablets, B.P. Chorea
Hyperactive states of organic or
toxic delirium Major psychoses
including- Major organic pyschoses
including arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients
under the age of 16 years
44 Cholestyramine . . . . . . With the written authority of the
Secretary-
Bile salt malabsorption associated
with ileal resection or proven ileal
disease
Pruritus associated with partial
biliary obstruction not responding
toother therapy
Hypercholesterolaemia
45 Cimetidine . . . . . . . . With the written authority of the
Secretary-
Duodenal ulcer (including pyloric
ulcer), confirmed by radiology,
endoscopy or surgery
Gastric ulcer, confirmed by
radiology, endoscopy or surgery
Severe ulcerating oesophagitis,
confirmed by endoscopy
Ulcerating oesophagitis in
scleroderma
Zollinger-Ellison syndrome, proven
by investigation
46 (1) Clindamycin Capsules,
B.P. (2) Clindamycin
Palmitate Hydrochloride Gram-positive coccal infections
where the infection cannot be safely
and effectively treated with
penicillin or a derivative of
penicillin
47 Clofibrate Capsules, B.P. . With the written authority of the
Secretary-
Hypertriglyceridaemia
Hypercholesterolaemia
48 (1) Cloxacillin Capsules,
B.P. (2) Cloxacillin
Sodium, B.P., with
Purified Water, B.P. With the written authority of the
Secretary- Infections due to the
presence of penicillin-resistant
staphylococci Osteomyelitis
49 Codeine Phosphate, B.P.,
with Aspirin, B.P.,
Tablets, 30 mg-325 mg With the written authority of the
Secretary- Disabling pain
associated with proven malignant
neoplasia
50 Colestipol Hydrochloride . With the written authority of the
Secretary-
Hypercholesterolaemia
51 Cyanocobalamin Injection,
B.P. . . . . . . . . . . . Pernicious anaemia and other proven
Vitamin B12 deficiencies
Post-gastrectomy treatment
Sub-acute combined degeneration of
the cord
52 (1) Cyclophosphamide, B.P. With the written authority of the
Secretary-
(2) Cyclophosphamide Anaemia, autoimmune, haemolytic
Tablets, B.P. Arthritis, rheumatoid with
vasculitis or visceral complications
Continuing cyclophosphamide therapy
initiated in a hospital
Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active, chronic
Lupus erythematosus, systemic
Malignant disease including
leukaemia
Nephritis
Nephrotic syndrome
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
53 Danazol . . . . . . . . . . With the written authority of the
Secretary-
Endometriosis, proven by visual
means
Hereditary angio-oedema
54 Dantrolene Sodium . . . . . With the written authority of the
Secretary-
Treatment of chronic spasticity
55 "DE-LACT INFANT" . . . . . Acute gastro-enteritis complicated
by lactose intolerance in infants
under the age of 12 months
Proven lactose intolerance in
infants under the age of 12 months
56 Demeclocycline Capsules, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Syndrome of inappropriate
antidiuretic hormone secretion,
caused otherwise than by treatment
with a drug
57 Deodorant Detergent
Solution
(Lauryldimethylbenzyl
Ammo- nium Chloride and
"TERIC N8") Any disease or condition in a
paraplegic or quadriplegic patient
Ileostomyor colostomy conditions
58 Dexamethasone Sodium
Phosphate, B.P., Injection
equivalent of
Dexamethasone Phosphate
120 mg in 5 mL For use in a hospital
59 Dexamphetamine Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
For the treatment of a patient
under the age of 21 years and who is
hyperkinetic as a result of brain
damage
Narcolepsy
60 (1) Dextromoramide
Tablets, B.P. (2)
Dextromoramide Tartrate, B.
P. (3) Dextromoramide
Tartrate Injec tion, B.P. Disabling pain associated with
proven malignant neoplasia
61 "DIGESTELACT" . . . . . . . With the written authority of the
Secretary-
Lactose intolerance
62 Dihydrotachysterol, B.P. . With the written authority of the
Secretary-
Hypoparathyroidism
Osteomalacia following gastrectomy,
severe steatorrhoea or renal failure
Vitamin D-resistant rickets
63 Dimethicones, B.P.,
Aerosol Spray Ileostomy or colostomy conditions
64 Dimethicones, B.P., Creams Any disease or condition in a
paraplegicor quadriplegic patient
Ileostomy or colostomy conditions
Use with surgical appliances
65 Dioctyl Sodium
Sulphosuccinate with
Bisacodyl, B.P. Any disease or condition in a
paraplegic or quadriplegic patient
For use by patients who are
receiving long-term extensive
nursing care in hospitals or nursing
homes
For use by patients for whose care a
Commonwealth Domiciliary Nursing
Care Benefit is approved
66 Dipyridamole Tablets, B.P. With the written authority of the
Secretary-
Biopsy proven glomerulonephritis
Mesangiocapillary renal disease
Renal allograft
Patients with cardiac valve
prosthesis
67 Doxepin Hydrochloride, B.P.
, Tablets, 50mg (base) With the written authority of the
Secretary- Endogenous depression
where there is an inadequate
response to not less than100 mg of
doxepin daily
68 (1) Doxycycline
Hydrochloride, B.P.,
Capsules, 50mg (base)
(containing enteric coated
pellets) (2) Doxycycline
Hydrochloride, B.P.,
Tablets, 50 mg (base) Bronchiectasis in patients over the
age of 8 years Chronic bronchitis in
patients over the age of 8 years
Severe acne
69 Dydrogesterone Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Endometriosis, proven by visual
means
70 Ergocalciferol, B.P. . . . Hypocalcaemia
Hypoparathyroidism
Osteomalacia following gastrectomy,
severe steatorrhoea or renal failure
Vitamin D-resistant rickets
71 Ethacrynic Acid Tablets, B.
P. . . . . . . . . . . . . Patients who are hypersensitive to
other oral diuretics
72 Ethyloestrenol Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Osteoporosis
Patients on long-term treatment with
cortico steroids
73 Etretinate . . . . . . . . With the written authority of the
Secretary-
Treatment initiated in a hospital
of-
Darier's disease
Erythrokeratoderma
Pityriasis rubra pilaris
Severe congenital ichthyosis
(lamellar, bullous and sex linked)
Severe intractable psoriasis
Severe palmo-plantar keratoderma
For the continuing treatment of a
patient who has already received,
for more than 6 months, therapy with
etretinate for a condition listed
above
74 (1) Flucloxacillin
Capsules, B.P. (2)
Flucloxacillin Sodium, B.P.
, with Purified Water,
B.P. With the written authority of the
Secretary- Infections due to the
presence of penicillin-resistant
staphylococci Osteomyelitis
75 Flucytosine Tablets, B.P. . Invasive or systemic fungal
infections such as candidiasis,
cryptococcosis and
chromoblastomycosis
76 Fluoxymesterone Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Aplastic anaemias, proven
Carcinoma of the breast
Hypogonadism
Osteoporosis
77 (1) Fluphenazine Decanoate
Injection, B.P. Chorea
Hyperactive states of organic or
toxic delirium
(2) Fluphenazine
Hydrochloride, B.P.
(3) Fluphenazine Tablets,
B.P. Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
78 Fosfestrol Sodium, B.P. . . Carcinoma of the prostate
79 Frusemide Tablets, B.P.,
500 mg . . . . . . . . . . Renal failure
80 Fusidic Acid, B.P. . . . . With the written authority of the
Secretary-
For use in combination with another
antibiotic in the treatment of
serious staphylococcal infections
confirmed by bacteriological evidence
81 "GALACTOMIN FORMULA
No. 17" With the written authority of the
Secretary- Galactosaemia
Conditions needing an extreme
restriction of lactose in the diet
of a patient under the age of 4 years
82 "GALACTOMIN FORMULA
No. 19" With the written authority of the
Secretary- Glucose-galactose
malabsorption
83 "GLUCOSE NUTRAMIGEN" With the written authority of the
Secretary-
Cows' milk allergy in children
under the age of 2 years
Cystic fibrosis (mucoviscidosis)
Galactosaemia
Glycogen storage disease due to
glucose-6- phosphatase deficiency in
children under the age of 2 years
Lactose intolerance
84 Griseofulvin Tablets, B.P. Recalcitrant tinea infections
Kerion
85 (1) Haloperidol, B.P. Chorea
(2) Haloperidol Tablets,
B.P. Hyperactive states of organic or
toxic delirium
Malignant neoplasia (late stage)
Radiation sickness
Major psychoses including-
Major organic psychoses
including arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
86 Hydrocortisone Acetate, B.
P., Rectal Foam Proctitis
Ulcerative colitis
87 Hydrocortisone Acetate
Injection, B.P. Alopecia areata
For local intra-articular or
peri-articular infiltration
Granulomata, dermal
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
88 Hydrocortisone Sodium
Succinate, B.P., Injection,
500 mg Any disease or condition in a
patient receiving treatment in a
hospital
89 "INFASOY" . . . . . . . . . With the written authority of the
Secretary-
Cows' milk allergy in children
under the age of 2 years
Galactosaemia
Homocystinuria
Lactose intolerance
90 Influenza Vaccine (Split
Virion), Inactivated, B.P. For prophylaxis of persons at
special risk of adverse consequences
from infections of the lower
respiratory tract
91 "ISOMIL" . . . . . . . . . With the written authority of the
Secretary-
Cows' milk allergy in children
under the age of 2 years
Galactosaemia
Homocystinuria
Lactose intolerance
92 Isopropyl Monoester
Polymer with Isopropyl
Alcohol, B.P. Ileostomy or colostomy conditions
93 (1) "KETOVITE" Liquid With the written authority of the
Secretary-
(2) "KETOVITE" Tablets Galactosaemia
Persistent monosaccharide
intolerance
Phenylketonuria
Tyrosinosis (hereditary)
94 Lactulose Solution, B.P. . With the written authority of the
Secretary-
Hepatic coma or pre-coma (chronic
porto-systemic encephalopathy)
Terminal malignant neoplasia
95 Lincomycin Injection, B.P. Gram-positive coccal infections
where these cannot be safely and
effectively treated with penicillin
or a derivativeof penicillin
96 "LOCASOL" . . . . . . . . . With the written authority of the
Secretary-
Hypercalcaemia in children under
the age of 2 years
Osteopetrosis
97 (1) "LOFENALAC" Phenylketonuria
(2) "MAXAMAID XP"
98 (1) Medroxyprogesterone
Acetate, B.P., Injection,
50 mg in 1 mL
(2) Medroxyprogesterone
Acetate, B.P., Tablets,
100 mg Breast cancer
Endometrial cancer
Renal cell cancer
99 Medroxyprogesterone
Acetate, B.P., Injection,
150 mg in 1 mL Breast cancer
Endometrial cancer
Precocious puberty
Renal cell cancer
100 Medroxyprogesterone
Acetate, B.P., Tablets, 2.
5 mg Dysfunctional uterine bleeding
Precocious puberty
Turner's syndrome
101 Medroxyprogesterone
Acetate, B.P., Tablets, 10
mg Breast cancer
Dysfunctional uterine bleeding
Endometrial cancer
Endometriosis
Precocious puberty
Renal cell cancer
Turner's syndrome
102 (1) Methadone Injection,
B.P. (2) Methadone
Tablets, B.P. Disabling pain associated with
proven malignant neoplasia
Disabling painof short duration not
responding to non-narcotic
analgesics, the maximum duration of
treatment being two weeks
103 Methenolone Acetate . . . . With the written authority of the
Secretary-
Osteoporosis
Patients on long-term treatment with
corticosteroids
104 (1) Methotrexate, B.P., 5
mg Injection With the written authority of the
Secretary- Acute leukaemia
(2) Methotrexate
Injection, B.P., 5 mg Breast cancer
Chorioadenoma destruens
(3) Methotrexate Tablets,
B.P. Continuing methotrexate therapy
initiated in a hospital
Gestational choriocarcinoma
Head and neck epidermoid cell
carcinoma
Hydatidiform mole
Lung cancer
Lymphoma
Osteogenic sarcoma
Pemphigus
Severe intractable or extensive
psoriasis
105 (1) Methotrexate, B.P.,
50 mg Injection With the written authority of the
Secretary- Carcinoma of the breast
(2) Methotrexate
Injection, B.P., 50 mg Continuing methotrexate therapy
initiated in a hospital
Head and neck epidermoid cell
carcinoma
Lymphoma
Osteogenic sarcoma
Pemphigus
106 Methylphenobarbitone, B.P. Epilepsy
107 Methylprednisolone Acetate
Injection, B.P. For local intra-articular or
peri-articular infiltration
108 Methyltestosterone Tablets,
B.P., 5 mg Hypogonadism in patients under the
age of 16 years
109 Methyltestosterone Tablets,
B.P., 25 mg or 50 mg Carcinoma of the breast
Hypogonadism
Klinefelter's syndrome (seminiferous
tubule dysgenesis)
110 Metronidazole, B.P. . . . . With the written authority of the
Secretary- Treatment in a hospital
of acute anaerobic sepsis
111 Mianserin Hydrochloride
Tablets, B.P. With the written authority of the
Secretary- Depressive illness in
persons with cardiovascular disease
112 Minoxidil . . . . . . . . . With the written authority of the
Secretary-
For the continuing treatment of
severe refractory hypertensive
diseasewhere treatment with
minoxidil was initiated in a hospital
For the continuing treatment of a
patient who has already received,
for more than 6 months, therapy with
minoxidil for severe refractory
hypertension
113 Mithramycin . . . . . . . . For use in a hospital for-
Inoperable testicular neoplasm
Symptomatic hypercalcaemia and
hypercalcinuria associated with
advanced neoplasia
114 Morphine Sulphate, B.P.,
with Tacrine Hydrochloride Severe intractable pain
115 (1) Nalidixic Acid
Mixture, B.P. With the written authority of the
Secretary-
(2) Nalidixic Acid
Tablets, B.P. For use as a urinary antiseptic in
patients with neurogenic bladder
Urinary tract infections where
current clinical and bacteriological
evidence confirms that nalidixic
acid is the most appropriate
therapeutic agent
116 (1) Nandrolone Decanoate
Injection, B.P.
(2) Nandrolone
Phenylpropionate Injection,
B.P. With the written authority of the
Secretary- Carcinoma of the breast
Osteoporosis
Patients on long-term treatment with
corticosteroids
117 Neomycin Tablets, B.P. . . Acute leukaemia during induction of
remission with chemotherapy
Bowel sterilisation preparatory to
major surgery
Encephalopathy, hepatic
118 Nifedipine . . . . . . . . Anigina
119 (1) Nitrofurantoin, B.P.
(2) Nitrofurantoin
Mixture, B.P. (3)
Nitrofurantoin Tablets, B.
P. Urinary tract infections by
organisms where sulphonamide
treatment has proved ineffective and
positive bacteriological evidence
confirms that the organisms are
sensitive to nitrofurantoin, or
where the patient is sensitive to
sulphonamides
120 Norethisterone Acetate, B.
P., Tablets, 2.5 mg Dysfunctional uterine bleeding
Endometriosis
Precocious puberty
Turner's syndrome
121 Norethisterone Acetate, B.
P., Tablets, 10 mg Malignant neoplasia
122 Norethisterone Tablets, B.
P., 5 mg Benign mammary dysplasia
Dysfunctional uterine bleeding
Endometriosis
Precocious puberty
Turner's syndrome
123 "ODORTROL" Ileostomy or colostomy conditions
124 Orphenadrine Hydrochloride
Tablets, B.P. Parkinsonism
125 (1) Oxycodone
Hydrochloride (2)
Oxycodone Pectinate Disabling pain associated with
proven malignant neoplasia
126 Oxymetholone Tablets, B.P. With the written authority of the
Secretary-
Proven aplastic anaemias
Myelosclerosis
127 (1) Pancreatin Enzyme, 4
times U.S.N.F. XIII
strength Cystic fibrosis (mucoviscidosis)
Following pancreatico-duodenectomy
(2) Pancreatin Enzyme, 5
times U.S.N.F. XIV strength Pancreatic steatorrhoea
(3) Pancrelipase
128 Papaveretum, Tablets . . . Disabling pain associated with
proven malignant neo- plasia
Disabling pain of short duration not
responding to non-narcotic
analgesics, the maximum duration of
treatment being two weeks
129 (1) Penicillamine, B.P. . With the written authority of the
Secretary-
(2) Penicillamine Tablets,
B.P. Acute heavy metal intoxication
Cystinosis
Cystinuria with calculus formation
Haemoglobinuria, paroxysmal cold
Severe rheumatoid arthritis
Wilson's disease (hepatolenticular
degeneration)
130 Perhexiline Maleate . . . . With the written authority of the
Secretary-
Angina not responding to other
therapy
131 Pericyazine . . . . . . . . Chorea
Hyperactive states of organic or
toxic delirium
Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients
under the age of 16 years
132 Phenelzine Tablets, B.P. . With the written authority of the
Secretary-
Depressive illness resistant to
treatment with either tricyclic
antidepressants or electroconvulsive
therapy
Phobic states
133 (1) Phenobarbitone, B.P. . Epilepsy
(2) Phenobarbitone
Injection, B.P.
(3) Phenobarbitone Sodium,
B.P.
(4) Phenobarbitone
Tablets, B.P.
134 Phenoxybenzamine Capsules,
B.P. With the written authority of the
Secretary- Neurogenic urinary
retention
Phaeochromocytoma
135 Pilocarpine . . . . . . . . With the written authority of the
Secretary-
Chronic glaucoma when other miotics
are not tolerated
136 (1) "PK AID I" Phenylketonuria
(2) "PK AID II"
137 Pneumococcal Vaccine,
Polyvalent Splenectomised persons over the age
of 2 years
Persons with Hodgkin's disease
Persons at high risk of pneumococcal
infections
138 Polyestradiol Phosphate . . Carcinoma of the breast
Carcinoma of the prostate
139 Polyisobutylene . . . . . . Ileostomy or colostomy conditions
140 Polyvinylpyrrolidone and
Vinyl Acetate Copolymer Ileostomy or colostomy conditions
141 "PORTAGEN" . . . . . . . . With the written authority of the
Secretary-
Patients requiring a ketogenic diet
for intractable childhood epilepsy
Proven malabsorption
142 Potassium Bicarbonate
Effervescent Tablets With the written authority of the
Secretary- Hyperchloraemic
hypokalaemicacidosis
143 Prednisolone Acetate
Injection For local intra-articular or
peri-articular infiltration
144 Prednisolone Acetate with
Phenylephrine
Hydrochloride, B.P. Corneal grafts
Uveitis
145 Prednisolone Sodium
Phosphate, B.P., Retention
Enema and Suppositories Ulcerative colitis
Proctitis
146 "PREGESTIMIL" . . . . . . . With the written authority of the
Secretary-
Biliary atresia
Cystic fibrosis
Enterokinase deficiency
Intolerance to both milk protein
and soya protein
Severe diarrhoea of greater than
two weeks duration in infants under
the age of 4 months
147 Procarbazine Hydrochloride With the written authority of the
Secretary- Lymphoma
Small cell carcinoma of the lung
148 Propantheline Tablets, B.P. With the written authority of the
Secretary-
Chronic neurogenic incontinence of
urine
149 "PROSOBEE" . . . . . . . . With the written authority of the
Secretary-
Cows' milk allergy in children
under the age of 2 years
Galactosaemia
Homocystinuria
Lactose intolerance
150 Pyridoxine Hydrochloride
Tablets, B.P. Anaemia proved to be responsive to
pyridoxine Convulsions responsive to
pyridoxine
Homocystinuria
Primary hyperoxaluria
Radiation sickness
Sideroblastic (refractory) anaemia
Treatment and prophylaxis of
peripheral neuritis caused or likely
to becaused by isoniazid therapy
151 Ranitidine Hydrochloride . With the written authority of the
Secretary-
Duodenal ulcer (including pyloric
ulcer), confirmed by radiology,
endoscopy or surgery
Gastric ulcer, confirmed by
radiology, endoscopy or surgery
Severe ulcerating oesophagitis,
confirmed by endoscopy
Ulcerating oesophagitis in
scleroderma
Zollinger-Ellison syndrome, proven
by investigation
152 Rifampicin, B.P. . . . . . With the written authority of the
Secretary-
Leprosy in adults
Prophylaxis of meningococcal
disease in close contacts and
carriers
153 Silver Sulphadiazine with
Chlorhexidine Gluconate
Cream With the written authority of the
Secretary- Treatment, in a hospital,
ofburns
154 Sodium Cromoglycate, B.P.,
Eye Drops With the written authority of the
Secretary- Vernal
kerato-conjunctivitis
155 Sodium Cromoglycate, B.P.,
Nebuliser Solution Use in a power-operated nebuliser
for prophylaxis of asthma in persons
who are unable to use the capsule or
metered aerosol spray for oral
inhalation
156 Sodium Fusidate, B.P. . . . With the written authority of the
Secretary- For use in combination
with another antibiotic in the
treatment of seriousstaphylococcal
infections confirmed by
bacteriological evidence
157 Spironolactone Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Primary hyperaldosteronism
Secondary hyperaldosteronism
158 Sterculia, B.P. . . . . . . Ileostomy or colostomy conditions
159 Sucralfate . . . . . . . . With the written authority of the
Secretary-
Duodenal ulcer (including pyloric
ulcer), confirmed by radiology,
endoscopy or surgery
Gastric ulcer, confirmed by
radiology, endoscopy or surgery
160 Sulindac Tablets, B.P. . . Osteoarthritis
Rheumatoid arthritis
161 Sulphasalazine . . . . . . Crohn's disease
Ulcerative colitis
162 Sulphinpyrazone Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Glomerulonephritis
Gout
Renal transplantation
163 (1) Surgical Cement
(2) Surgical Cement
Solvent Any disease or condition in a
paraplegic or quadriplegic patient
For use with surgical appliances
Ileostomy or colostomy conditions
164 Tamoxifen Citrate Tablets,
B.P. . . . . . . . . . . . With the written authority of the
Secretary- Treatment of
post-menopausal recurrent or
metastatic breast cancer
165 (1) Testosterone
Enanthate, B.P. (2)
Testosterone Propionate
In- jection, B.P. Carcinoma of the breast
Hypogonadism
Klinefelter's syndrome (seminiferous
tubule dysgenesis)
166 (1) Testosterone
Propionate, B.P., with
Testosterone Phenyl-
propionate, B.P., and
Testosterone Isocaproate,
B.P. (2) Testosterone
Propionate, B.P., with
Testosterone Phenyl-
propionate, B.P.,
Testosterone Isocaproate,
B.P., and Testosterone
Decanoate, B.P. Carcinoma of the breast
Gigantism
Hypogonadism
Klinefelter's syndrome (seminiferous
tubule dysgenesis)
167 Tetrabenazine . . . . . . . With the written authority of the
Secretary- Chorea not adequately
controlled by other drug therapy
168 Tetracosactrin Zinc
Injection, B.P. With the written authority of the
Secretary- Hypsarrhythmia
Multiple sclerosis, acute
exacerbation
Treatment of children who need
long-term corticosteroid therapy but
who are in danger of growth
suppression as a result
Treatment of patients who are being
withdrawn from long-term
corticosteroid therapy
Ulcerative colitis, proven, not
responding to parenteral
corticosteroids
169 Thiopropazate Hydrochloride
Tablets, B.P. Chorea
170 (1) Thioridazine
Hydrochloride, B.P. Chorea
Hyperactive states of organic or
toxic delirium
(2) Thioridazine Tablets,
B.P. Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients
under the age of 16 years
171 Ticarcillin Sodium . . . . With the written authority of the
Secretary-
Infections where positive
bacteriological evidence confirms
that ticarcillin sodium is the most
appropriate therapeutic agent
Septicaemia, suspected or proven
172 Tobramycin Injection, B.P. With the written authority of the
Secretary-
Infections where positive
bacteriological evidence confirms
that tobramycin sulphate is the most
appropriate antibiotic
Septicaemia, suspected or proven
173 Tocainide Hydrochloride . . Ventricular arrhythmias
174 Tranexamic Acid Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary- Hereditary angio-oedema
175 Tranylcypromine Tablets, B.
P. . . . . . . . . . . . . With the written authority of the
Secretary-
Depressive illness resistant to
treatment with either tricyclic
antidepressants or electroconvulsive
therapy
Phobic states
176 Triamcinolone Acetonide, B.
P., Injection Alopecia areata
For local intra-articular or
peri-articular infiltration
Granulomata, dermal
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
Necrobiosis lipoidica
Psoriasis
177 (1) Trifluoperazine
Hydrochloride, B.P. Chorea
Hyperactive states of organic or
toxic delirium
(2) Trifluoperazine
Hydrochloride Tablets, B.P. Major psychoses including-
Major organic psychoses including
arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients
under the age of 16 years
178 Triglycerides Oil, Medium
Chain With the written authority of the
Secretary- Abetalipoproteinaemia
Intestinal lymphangiectasia
Intractable childhood epilepsy
requiring a ketogenic diet
Short-term nutritional support in
severe steatorrhoea
Steatorrhoea due to distal small
bowel resection
179 Trimethoprim Tablets, B.P. Acute urinary tract infections
180 Trimipramine . . . . . . . With the written authority of the
Secretary-
Endogenous depression where there
is an inadequate response to not
less than 100 mg of trimipramine
daily
181 Trioxysalen . . . . . . . . Vitiligo
182 Tri-potassium Di-citrato
Bismuthate Complex With the written authority of the
Secretary- Duodenal ulcer
(including pyloric ulcer), confirmed
by radiology, endoscopy or surgery
Gastric ulcer, confirmed by
radiology, endoscopy or surgery
183 Vancomycin Hydrochloride,
B.P. . . . . . . . . . . . Any disease or condition in a
patient receiving treatment in a
hospital
Endophthalmitis
184 Vidarabine . . . . . . . . Eye infections caused by herpes
simplex virus where idoxuridine has
proved ineffective
185 "ZERODOR" . . . . . . . . . Ileostomy or colostomy conditions
186 "ZOFF" . . . . . . . . . . Any disease or condition in a
paraplegic or quadriplegicpatient
For use with surgical appliances
Ileostomy or colostomy conditions
AustLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback